Likely Steps in Benign Prostatic Hyperplasia's Development Traced in Cultured ...
As men age, their prostates grow, and a fair number will develop BPH. Although this disease — common in aging societies — can have troubling symptoms, it is not always an indicator of a serious medical problem. Right now, there is no cure for the ...
BPH News - Wed, 10 Feb 2016 10:22



A possible relationship between serum sex hormones and benign prostatic ...
In this study, we examined the relationship between sex hormone levels and lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH) who underwent transurethral surgery. The study was conducted in 158 patients who came to our ...
UroToday - Tue, 09 Feb 2016 00:15

LUTS/BPH Patients with Large Prostates May Benefit from Higher Naftopidil Dose
BPH News - Tue, 09 Feb 2016 10:00



Combination Procedure for Benign Prostate Hyperplasia Shows Early Promise
The team enrolled 340 benign prostatic hyperplasia patients ages 62-86 who underwent treatment with two-micron laser vaporesection plus TURP. The trial analyzed the following data from each patient from the time they started the procedure until three ...
BPH News - Wed, 20 Jan 2016 15:50

Benign prostatic hyperplasia and lower urinary tract symptoms. A review of ...
CONTEXT - The treatment of benign prostatic hyperplasia (BPH) is changing due to a greater understanding of the disease and the development of the functional concept of lower urinary tract symptoms (LUTS). OBJECTIVES - To describe the current state of ...
UroToday - Fri, 05 Feb 2016 00:09



Unichem gets USFDA approval to sell tablets for treatment of prostatic hyperplasia
The medicine is used in the treatment of benign prostatic hyperplasia in adults. Alfuzosin hydrochloride extended-release tablets USP is the company's first PARA IV ANDA approval from the USFDA. “The product will be commercialized from Unichem's Goa ...
The American Bazaar - Fri, 29 Jan 2016 12:48

Unichem Lab receives final ANDA approval for Alfuzosin Hydrochloride Tablets
Mint Market Info - Fri, 29 Jan 2016 01:33

Differential blood-based diagnosis between benign prostatic hyperplasia and ...
However, the potential of blood-based miRNAs for the differential diagnosis of PCa and benign prostatic hyperplasia (BPH) has not been tested. We compared the miRNome from blood of PCa and BPH patients and further investigated the influence of the ...
UroToday - Tue, 09 Feb 2016 00:15

Classification and surgical treatment for 180 cases of adrenocortical ...
METHODS - A retrospective analysis was done to 180 adrenocortical hyperplasia patients (74 males, 109 females, aged 6~76 (average 40. 1). Studies were done to the relationship between patients' clinical characteristics, biochemical, endocrinological ...
UroToday - Mon, 18 Jan 2016 00:09

The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary ...
As part of its Medical Technologies Evaluation Programme (MTEP), the National Institute for Health and Care Excellence (NICE) invited Neotract (manufacturer) to submit clinical and economic evidence for their prostatic urethral lift device, Urolift ...
UroToday - Thu, 11 Feb 2016 00:15


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014